BC Innovations | Aug 1, 2013
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Kallikrein-related peptidase 4 (KLK4) Cell culture and mouse studies suggest inhibition of KLK4 could help treat prostate cancer. In...
BC Innovations | Jul 16, 2009
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Kallikrein-related peptidase 4 (KLK4); protease-activated receptor 1 (PAR1); PAR2 Studies in cell culture identified a KLK4-selective inhibitor that could be useful for treating...
Items per page:
1 - 2 of 2